STRN-ALK (Sex3Aex20), Active (A19-19JG)
FOR BULK ORDER REQUESTS PLEASE CONTACT US
Description :Recombinant human fusion STRN (1-137a.a., exons1-3) - ALK (1058a.a.-end, exons20-29) protein was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag.
Species :Human
Tag :GST tag
Expression System:Sf9 insect cells using baculovirus
Sequence :STRN (1-137a.a., exons1-3) - ALK (1058a.a.-end, exons20-29)
Genbank Number 1:NM_003162
Genbank Number 2 :NM_004304
Specific Activity :Sample Kinase Activity Plot. For specific information on a given lot, see related technical data sheet.
Purity :Sample Purity Data. For specific information on a given lot, see related technical data sheet.
Storage, Stability and Shipping :Store product at –70oC. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.
Applications :Kinase Assay
Molecular Weight :110 kDa
Gene Aliases :STRN: PPP2R6A; SG2NA; STRN1
ALK: ALK (Ki-1), CD246
Scientific Background :Anaplastic large cell lymphomas are associated with chromosomal aberrations involving the anaplastic lymphoma kinase (ALK) gene, resulting in the expression of novel chimeric ALK proteins with transforming properties. Many chromosomal rearrangements leading to enhanced ALK activity have been described and are implicated in a number of cancer types (1). A fusion protein of STRN-ALK has been reported in a non-small cell lung cacner due to resistant to Alectinib (2).
References :
1. Palmer R H, et al: Anaplastic lymphoma kinase: signalling in development and disease. Biochem J. 2009 May 27;420(3):345-61.
2. Nakanishi Y, et al: Case Report of Non-Small Cell Lung Cancer with STRN-ALK Translocation: A Nonresponder to Alectinib. J Thorac Oncol. 2017 Dec;12(12):e202-e204.
Product Sheets (By Lot #) :
Research Areas :Cancer